Expression of the Multiple Sclerosis-Associated MHC Class II Allele Is Regulated by Vitamin D
Multiple sclerosis (MS) is a complex trait in which allelic variation in the MHC class II region exerts the single strongest effect on genetic risk. Epidemiological data in MS provide strong evidence that environmental factors act at a population level to influence the unusual geographical distribution of this disease. Growing evidence implicates sunlight or vitamin D as a key environmental factor in aetiology. We hypothesised that this environmental candidate might interact with inherited factors and sought responsive regulatory elements in the MHC class II region. Sequence analysis localised a single MHC vitamin D response element (VDRE) to the promoter region of HLA-DRB1. Sequencing of this promoter in greater than 1,000 chromosomes from HLA-DRB1 homozygotes showed absolute conservation of this putative VDRE on HLA-DRB1*15 haplotypes. In contrast, there was striking variation among non–MS-associated haplotypes. Electrophoretic mobility shift assays showed specific recruitment of vitamin D receptor to the VDRE in the HLA-DRB1*15 promoter, confirmed by chromatin immunoprecipitation experiments using lymphoblastoid cells homozygous for HLA-DRB1*15. Transient transfection using a luciferase reporter assay showed a functional role for this VDRE. B cells transiently transfected with the HLA-DRB1*15 gene promoter showed increased expression on stimulation with 1,25-dihydroxyvitamin D3 (P = 0.002) that was lost both on deletion of the VDRE or with the homologous “VDRE” sequence found in non–MS-associated HLA-DRB1 haplotypes. Flow cytometric analysis showed a specific increase in the cell surface expression of HLA-DRB1 upon addition of vitamin D only in HLA-DRB1*15 bearing lymphoblastoid cells. This study further implicates vitamin D as a strong environmental candidate in MS by demonstrating direct functional interaction with the major locus determining genetic susceptibility. These findings support a connection between the main epidemiological and genetic features of this disease with major practical implications for studies of disease mechanism and prevention.
Vyšlo v časopise:
Expression of the Multiple Sclerosis-Associated MHC Class II Allele Is Regulated by Vitamin D. PLoS Genet 5(2): e32767. doi:10.1371/journal.pgen.1000369
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1000369
Souhrn
Multiple sclerosis (MS) is a complex trait in which allelic variation in the MHC class II region exerts the single strongest effect on genetic risk. Epidemiological data in MS provide strong evidence that environmental factors act at a population level to influence the unusual geographical distribution of this disease. Growing evidence implicates sunlight or vitamin D as a key environmental factor in aetiology. We hypothesised that this environmental candidate might interact with inherited factors and sought responsive regulatory elements in the MHC class II region. Sequence analysis localised a single MHC vitamin D response element (VDRE) to the promoter region of HLA-DRB1. Sequencing of this promoter in greater than 1,000 chromosomes from HLA-DRB1 homozygotes showed absolute conservation of this putative VDRE on HLA-DRB1*15 haplotypes. In contrast, there was striking variation among non–MS-associated haplotypes. Electrophoretic mobility shift assays showed specific recruitment of vitamin D receptor to the VDRE in the HLA-DRB1*15 promoter, confirmed by chromatin immunoprecipitation experiments using lymphoblastoid cells homozygous for HLA-DRB1*15. Transient transfection using a luciferase reporter assay showed a functional role for this VDRE. B cells transiently transfected with the HLA-DRB1*15 gene promoter showed increased expression on stimulation with 1,25-dihydroxyvitamin D3 (P = 0.002) that was lost both on deletion of the VDRE or with the homologous “VDRE” sequence found in non–MS-associated HLA-DRB1 haplotypes. Flow cytometric analysis showed a specific increase in the cell surface expression of HLA-DRB1 upon addition of vitamin D only in HLA-DRB1*15 bearing lymphoblastoid cells. This study further implicates vitamin D as a strong environmental candidate in MS by demonstrating direct functional interaction with the major locus determining genetic susceptibility. These findings support a connection between the main epidemiological and genetic features of this disease with major practical implications for studies of disease mechanism and prevention.
Zdroje
1. NoseworthyJH
LucchinettiC
RodriguezM
WeinshenkerBG
2000 Multiple sclerosis. N Engl J Med 343 938 952
2. EbersGC
2008 Environmental factors and multiple sclerosis. Lancet Neurol 7 268 277
3. RamagopalanSV
EbersGC
2008 Genes for multiple sclerosis. Lancet 371 283 285
4. LundmarkF
DuvefeltK
IacobaeusE
KockumI
WallstromE
2007 Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet
5. HaflerDA
CompstonA
SawcerS
LanderES
DalyMJ
2007 Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357 851 862
6. HoppenbrouwersIA
AulchenkoYS
EbersGC
RamagopalanSV
OostraBA
2008 EVI5 is a risk gene for multiple sclerosis. Genes Immun
7. AulchenkoYS
HoppenbrouwersIA
RamagopalanSV
BroerL
JafariN
2008 Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet
8. FogdellA
HillertJ
SachsC
OlerupO
1995 The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens 46 333 336
9. DymentDA
HerreraBM
CaderMZ
WillerCJ
LincolnMR
2005 Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 14 2019 2026
10. RamagopalanSV
MorrisAP
DymentDA
HerreraBM
DelucaGC
2007 The Inheritance of Resistance Alleles in Multiple Sclerosis. PLoS Genet 3 e150
11. ModinH
OlssonW
HillertJ
MastermanT
2004 Modes of action of HLA-DR susceptibility specificities in multiple sclerosis. Am J Hum Genet 74 1321 1322
12. MarrosuMG
MurruMR
CostaG
CuccaF
SotgiuS
1997 Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am J Hum Genet 61 454 457
13. DeLucaGC
RamagopalanSV
HerreraBM
DymentDA
LincolnMR
2007 An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc Natl Acad Sci U S A 104 20896 20901
14. WillerCJ
DymentDA
RischNJ
SadovnickAD
EbersGC
2003 Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 100 12877 12882
15. HammondSR
McLeodJG
MillingenKS
Stewart-WynneEG
EnglishD
1988 The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 111(Pt 1) 1 25
16. PugliattiM
SotgiuS
RosatiG
2002 The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 104 182 191
17. AchesonED
BachrachCA
WrightFM
1960 Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatr Scand Suppl 35132 147
18. NievesJ
CosmanF
HerbertJ
ShenV
LindsayR
1994 High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44 1687 1692
19. MungerKL
LevinLI
HollisBW
HowardNS
AscherioA
2006 Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Jama 296 2832 2838
20. WillerCJ
DymentDA
SadovnickAD
RothwellPM
MurrayTJ
2005 Timing of birth and risk of multiple sclerosis: population based study. Bmj 330 120
21. SmoldersJ
DamoiseauxJ
MenheereP
HuppertsR
2008 Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol
22. FeldmanD
GlorieuxFH
PikeJW
2005 Vitamin D San Diego; London Academic Press
23. HolickMF
2003 Vitamin D: A millenium perspective. J Cell Biochem 88 296 307
24. RigbyWF
WaughM
GrazianoRF
1990 Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood 76 189 197
25. SkjodtH
HughesDE
DobsonPR
RussellRG
1990 Constitutive and inducible expression of HLA class II determinants by human osteoblast-like cells in vitro. J Clin Invest 85 1421 1426
26. SandelinA
AlkemaW
EngstromP
WassermanWW
LenhardB
2004 JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32 D91 94
27. DeanG
ElianM
1997 Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 63 565 568
28. EbersGC
SadovnickAD
RischNJ
1995 A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377 150 151
29. ReithW
LeibundGut-LandmannS
WaldburgerJM
2005 Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 5 793 806
30. AnderssonG
1998 Evolution of the human HLA-DR region. Front Biosci 3 d739 745
31. AhmadT
NevilleM
MarshallSE
ArmuzziA
Mulcahy-HawesK
2003 Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet 12 647 656
32. WalkerLS
AbbasAK
2002 The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2 11 19
33. YuS
CantornaMT
2008 The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci U S A 105 5207 5212
34. JablonskiNG
ChaplinG
2000 The evolution of human skin coloration. J Hum Evol 39 57 106
35. LookerAC
Dawson-HughesB
CalvoMS
GunterEW
SahyounNR
2002 Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30 771 777
36. SadovnickAD
RischNJ
EbersGC
1998 Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 25 216 221
37. KrugerA
QuackP
SchneiderPM
RittnerC
HohlerT
2001 Sequence analysis of the DRB1 promoter reveals limited polymorphism with no influence on gene expression. Genes Immun 2 211 215
38. KnightJC
KeatingBJ
KwiatkowskiDP
2004 Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1. Nat Genet 36 394 399
39. KnightJC
KeatingBJ
RockettKA
KwiatkowskiDP
2003 In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 33 469 475
40. SaramakiA
BanwellCM
CampbellMJ
CarlbergC
2006 Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 34 543 554
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2009 Číslo 2
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- The Individual Blood Cell Telomere Attrition Rate Is Telomere Length Dependent
- Conservation and Convergence of Colour Genetics: Mutations in Cavefish
- Expression of the Multiple Sclerosis-Associated MHC Class II Allele Is Regulated by Vitamin D
- When Segregation Hangs by a Thread